Abbott Laboratories (NYSE:ABT)

$ 112.415 0.105 (0.09%) Market Cap: 194.98 Bil Enterprise Value: 201.85 Bil PE Ratio: 34.17 PB Ratio: 4.90 GF Score: 93/100

Q3 2024 Abbott Laboratories Earnings Call Transcript
Oct 16, 2024

$117.82 (+1.53%)

Earnings
Q2 2024 Abbott Laboratories Earnings Call Transcript
Jul 18, 2024

$100.07 (-4.40%)

Earnings
Q1 2024 Abbott Laboratories Earnings Call Transcript
Apr 17, 2024

$105.9 (-3.03%)

Earnings
Q4 2023 Abbott Laboratories Earnings Call Transcript
Jan 24, 2024

$110.77 (-2.83%)

Earnings
Abbott Laboratories at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Q3 2023 Abbott Laboratories Earnings Call Transcript
Oct 18, 2023

$95.56 (+3.71%)

Earnings
Q2 2023 Abbott Laboratories Earnings Call Transcript
Jul 20, 2023

$111.83 (+4.24%)

Earnings
Q1 2023 Abbott Laboratories Earnings Call Transcript
Apr 19, 2023

$112.29 (+7.82%)

Earnings
Q4 2022 Abbott Laboratories Earnings Call Transcript
Jan 25, 2023

$111 (-1.36%)

Earnings
Abbott Laboratories at JPMorgan Healthcare Conference Transcript
Jan 10, 2023
Q3 2022 Abbott Laboratories Earnings Call Transcript
Oct 19, 2022

$98.11 (-6.54%)

Earnings
Q2 2022 Abbott Laboratories Earnings Call Transcript
Jul 20, 2022

$108.23 (-1.55%)

Earnings
Q1 2022 Abbott Laboratories Earnings Call Transcript
Apr 20, 2022

$122.64 (+2.22%)

Earnings
Q4 2021 Abbott Laboratories Earnings Call Transcript
Jan 26, 2022

$120.07 (-2.60%)

Earnings
Abbott Laboratories at JPMorgan Healthcare Conference Transcript
Jan 11, 2022
Q3 2021 Abbott Laboratories Earnings Call Transcript
Oct 20, 2021

$123.31 (+3.33%)

Earnings
Q2 2021 Abbott Laboratories Earnings Call Transcript
Jul 22, 2021

$118.25 (-0.61%)

Earnings
Abbott Laboratories to Discuss Updated 2021 Outlook Call Transcript
Jun 01, 2021
Q1 2021 Abbott Laboratories Earnings Call Transcript
Apr 20, 2021

$120 (-3.64%)

Earnings
Q4 2020 Abbott Laboratories Earnings Call Transcript
Jan 27, 2021

$114.29 (-0.38%)

Earnings
Abbott Laboratories at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Q3 2020 Abbott Laboratories Earnings Call Transcript
Oct 21, 2020

$105.93 (-2.24%)

Earnings
Q2 2020 Abbott Laboratories Earnings Call Transcript
Jul 16, 2020

$96.4 (-0.34%)

Earnings
Q1 2020 Abbott Laboratories Earnings Call Transcript
Apr 16, 2020

$96 (+5.56%)

Earnings
Q4 2019 Abbott Laboratories Earnings Call Transcript
Jan 22, 2020

$91.86 (+2.37%)

Earnings
Abbott Laboratories at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Q3 2019 Abbott Laboratories Earnings Call Transcript
Oct 16, 2019

$81.78 (-0.24%)

Earnings
Q2 2019 Abbott Laboratories Earnings Call Transcript
Jul 17, 2019

$85.76 (+3.13%)

Earnings
Abbott Laboratories at UBS Global Healthcare Conference Transcript
May 21, 2019
Q1 2019 Abbott Laboratories Earnings Call Transcript
Apr 17, 2019

$72.88 (-4.58%)

Earnings
Abbott Laboratories at Barclays Global Healthcare Conference Transcript
Mar 13, 2019
Q4 2018 Abbott Laboratories Earnings Call Transcript
Jan 23, 2019

$69.91 (-2.21%)

Earnings

Abbott Laboratories at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 05:00PM GMT

Release Date Price: $112.73 (+0.29%)

Transcript 8-K

Robert Justin Marcus

JPMorgan Chase & Co, Research Division - Analyst

Hi. Thanks, everyone. If we could take a seat and get started here. I'm Robbie Marcus, the Medtech analyst at JPMorgan. Really happy to introduce our next speaker, Robert Ford, the CEO of Abbott. We'll do a little bit of presentation, then I'll join them up here for Q&A. Robert?

Questions & Answers

Robert B. Ford

Abbott Laboratories - Chairman of the Board, President & CEO

Okay. Thanks, Robbie. Good morning, and thank you for being here and joining me today. Before I begin, let me start with forward-looking disclosure statement. At Abbott, our mission is to help people live better lives, fuller lives through better health. We help keep your heart healthy. We help nourish your body. We help you feel better and move better, deliver medicines and information you need to best manage your health. And we've done it for the last 135 years, improving people's health at all stages of life by tackling some of the world's most pressing health care challenges with our innovative

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.